Kimberly-Clark Conference: Powering Care Push, Suzano JV to Cut Volatility, Eyes Kenvue Deal

Key Points

• Powering Care focuses on volume-led growth through product innovation, a value-tier push and an evolved operating model that standardizes processes while keeping local market agility to drive performance and reinvestment.
• Management flagged near-term input-cost volatility, embedding about $50 million of gross inflation in Q2, noting roughly 80% of costs are contracted/hedged and warning a ~$100/barrel oil scenario could add an estimated $150–170 million in H2 that is not in current guidance.
• Kimberly‑Clark will sell 51% of its international family and professional tissue business to Suzano to stabilize pulp-linked earnings while retaining 49%, using cash proceeds to help fund the proposed Kenvue acquisition that management says expands the company into faster-growing health and wellness markets with a targeted $1.9 billion of cost synergies.

Kimberly-Clark NASDAQ: KMB executives outlined the company’s ongoing strategic shift during a London fireside chat, highlighting efforts to drive volume-led growth under its “Powering Care” strategy, reduce earnings volatility through an international tissue joint venture with Suzano, and expand into faster-growing consumer health categories through the proposed acquisition of Kenvue.

Management details “Powering Care” operating changes

Chairman and CEO Mike Hsu said the core goal of Powering Care is to create a “virtuous cycle of growth” by improving product performance to drive volume, strengthening marketing and in-store execution, and funding reinvestment through a more efficient cost structure. He described three major components of the strategy:

• Accelerate pioneering innovation: Hsu said the company set out to disprove the idea that categories like diapers and tissue are commodities, arguing “superior performance is possible, and it’s not only possible, but it’s necessary.”
• Improve cost structure and productivity: He said Kimberly-Clark has moved away from being a “decentralized confederation” toward more standardized processes, reflecting that consumers and efficient manufacturing methods are “more similar than they are different” across markets.
• Evolve the operating model: Hsu said the company is keeping local market agility while overlaying more global scale to help markets move faster.

Volume growth driven by product performance and value-tier focus

Asked about recent volume/mix gains, Hsu emphasized product differentiation and value. He argued that “superior product performance equals superior value,” noting that consumers “really notice differences in performance” in categories like diapers and feminine care. He said the company’s exposure to highly competitive Asian markets, including China, helped push innovation, with competition in China’s diaper category cited as particularly intense.

Hsu also pointed to a stronger focus on value tiers as consumer pressure has increased, particularly in North America. He said Kimberly-Clark decided it would not become “a niche premium company” and cited its U.S. Snug & Dry diaper line as an example where the company launched advanced technology in the value tier before introducing it in premium offerings. He also referenced a product pipeline that includes a “Gen 3 diaper core” currently contributing to growth, with “Gen 4 and 5” in development.

Input-cost volatility: Q2 inflation embedded, second-half scenario not in guidance

Executives also discussed how the company is handling volatility tied to Middle East conflict and oil markets. Hsu said management has become “very accustomed to dealing with these situations” and reiterated the company’s discipline around “PNOC,” or price net of commodity cost, which it expects to be neutral to positive over time.

CFO Nelson Urdaneta said Kimberly-Clark included an expectation of about $50 million of gross input cost inflation for the second quarter, largely tied to oil volatility, along with “a slight impact” from a California distribution center fire. He said approximately 80% of input costs are covered through contracts or hedging, and that roughly 25% of the cost basket is exposed to oil-linked costs, rising when distribution is included.

Urdaneta said the company expects to fully mitigate the second-quarter inflation as the year progresses, but noted uncertainty for the second half given continued volatility and supplier actions such as surcharges and force majeure declarations. He described a scenario analysis in which oil remains around $100 per barrel, producing an estimated $150 million to $170 million of gross input costs in the second half—an amount not included in guidance, nor any mitigating actions. He said the company expects more clarity after the second quarter and plans to provide an updated view with second-quarter results in August.

Suzano joint venture aimed at stabilizing international tissue earnings

Hsu said the 2025 agreement to sell 51% of the International Family and Professional tissue business to Suzano and form a joint venture is intended to “build a better tissue business.” He described Western Europe as a major component of that segment, where he said margins are “structurally lower” and earnings were “highly volatile” due to fluctuations in pulp costs.

He argued that Suzano’s fiber cost structure is “inherently stable,” and that combining Suzano’s strengths in pulp production and Kimberly-Clark’s strengths in tissue production and commercial execution could create a more effective business. Hsu said the partnership structure reflects that “we both bring strengths to the party that we both value,” and added it is possible Suzano could increase its ownership stake over time.

Urdaneta added that retaining a 49% stake allows shareholders to participate in future value creation, while the cash received at close is expected to be used as part of the cash consideration for the Kenvue acquisition, which he said would help maintain a strong balance sheet. He also noted the deal includes “a fixed mechanism” for Kimberly-Clark to exit when Suzano offers to purchase the remaining stake.

Kenvue acquisition framed as platform expansion into faster-growing health and wellness

Hsu said management views the planned Kenvue deal as creating “the preeminent health and wellness leader globally.” He contrasted Kimberly-Clark’s categories, which he said are growing roughly 2% to 2.5%, with Kenvue’s categories, which he said grow faster and benefit from “multi-decade tailwinds” such as global aging trends.

He also cited geographic and consumer-life-stage complementarity. Hsu said Kenvue has a sizable presence in Europe and India, while Kimberly-Clark is larger in markets like Mexico. He described an opportunity to grow both portfolios through distribution and to apply a digitally powered consumer engagement model that Kimberly-Clark has been developing in markets such as China, Korea, Indonesia, and Brazil. Hsu said the company’s e-commerce shares are “700 basis points higher in North America than our offline shares.”

Addressing skepticism that the categories are fundamentally different, Hsu argued the core Powering Care principles—need-state insight, technology pipelines, consumer engagement, and cost discipline—can apply to consumer health brands as well. He added that, despite Kenvue’s higher margin profile, Kimberly-Clark sees further opportunity to improve Kenvue margins through cost discipline.

On integration, Hsu said leadership selections followed a “rigorous” third-party assessment and emphasized choosing “the best of both.” He praised leaders from both organizations and said the company is “going all in on digital,” calling it a potential competitive advantage.

Urdaneta defended the company’s stated $1.9 billion cost synergy target—described in the discussion as 30% sales and marketing, 30% cost of goods sold, and 40% G&A, largely realized by year three—saying benchmarking in consumer health supports higher synergy percentages than traditional staples deals and that Kimberly-Clark’s recent execution on productivity and operating tools underpins confidence in delivery.

Executives also addressed questions about Kenvue’s brand complexity and potential portfolio actions. Hsu said the long tail of brands can appear more complex than it is operationally and said the tail is generally profitable, particularly in international markets where performance has been strong. Urdaneta said Kimberly-Clark would remain disciplined on portfolio management and capital allocation, pointing to past exits such as Brazilian tissue and professional operations, the personal protective equipment business, and private label exposure.

Finally, on liability concerns tied to Tylenol, Hsu said the company is confident in the science supporting acetaminophen’s safety and cited continued support from health agencies such as the U.S. FDA for use by pregnant women. He said Kimberly-Clark conducted extensive diligence with external advisors and litigation counsel and evaluated scenarios around potential outcomes, concluding the economics still support what he described as “generational value creation,” even under assumptions that include litigation costs.

About Kimberly-Clark NASDAQ: KMB

Kimberly-Clark Corporation is a U.S.-based multinational manufacturer of personal care and consumer tissue products. The company develops, produces and markets a range of consumer brands and professional products, including facial and bathroom tissues, disposable diapers and training pants, feminine care, incontinence products and workplace hygiene solutions. Known for consumer-facing names such as Kleenex, Huggies, Kotex, Cottonelle and Scott, as well as professional offerings under Kimberly-Clark Professional and KleenGuard, the company supplies goods to retail, healthcare and institutional customers.

Founded in 1872 in Neenah, Wisconsin, Kimberly-Clark has expanded from its 19th-century paper-making roots into a global household and workplace products company.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.